These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 12681166)

  • 1. [Review of plasma anti-aggregants and their indications in primary care. Eight years later].
    Blasco Valle M; Lucía Cuesta JF
    Aten Primaria; 2003 Mar; 31(4):252-63. PubMed ID: 12681166
    [No Abstract]   [Full Text] [Related]  

  • 2. [Platelet anti-aggregants, from the concept to clinical results].
    Tobelem G
    Rev Prat; 1988 Dec; 38(30):2268-71. PubMed ID: 3222655
    [No Abstract]   [Full Text] [Related]  

  • 3. [Platelet antiaggregants: a review of their indications in primary care].
    Blasco Valle M; Vitoria Lapeña A; Robledo E
    Aten Primaria; 1993 Feb; 11(3):142-6, 148-50. PubMed ID: 8453007
    [No Abstract]   [Full Text] [Related]  

  • 4. [The treatment of cerebrovascular disorders with anticoagulants and platelet aggregation inhibitors].
    Ameriso SF
    Rev Neurol; 1999 Dec 16-31; 29(12):1285-90. PubMed ID: 10652758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oral anticoagulants and platelet anti-aggregants in the prevention of metastases: state of the art and perspectives of a combined therapy].
    Finzi G; Dettori AG
    Recenti Prog Med; 1989 Jan; 80(1):28-32. PubMed ID: 2652221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Attempts to prevent intrauterine growth retardation using platelet anti-aggregants].
    Uzan S; Beaufils M
    Rev Fr Gynecol Obstet; 1990 Mar; 85(3):141-3. PubMed ID: 2333454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of ticlopidine in primary care].
    Oliver AC; Peralta JL
    Aten Primaria; 1996 Mar; 17(5):361-2. PubMed ID: 8722164
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of symptomatic patients with essential thrombocythemia: effectiveness of anagrelide.
    Cacciola RR; Cipolla A; Di Francesco E; Giustolisi R; Cacciola E
    Am J Hematol; 2005 Sep; 80(1):81-3. PubMed ID: 16138352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet therapy in women with acute coronary syndrome.
    Foody J
    J Fam Pract; 2014 Feb; 63(2 Suppl):S3-8. PubMed ID: 24527482
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular risk management in diabetes in primary care.
    Kalra S; Gupta Y
    J Pak Med Assoc; 2015 Aug; 65(8):907-8. PubMed ID: 26228345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meeting new challenges with antiplatelet therapy in primary care.
    Kuritzky L; Díez JG
    J Fam Pract; 2012 Jun; 61(6 Suppl):S22-8. PubMed ID: 22670232
    [No Abstract]   [Full Text] [Related]  

  • 12. Pre-operative use of anti-aggregants may reduce atrial fibrillation development rate during coronary bypass surgery.
    Balcı AY; Ozdemir F
    Anadolu Kardiyol Derg; 2012 Feb; 12(1):84. PubMed ID: 22231946
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevention with thrombocyte aggregation inhibitors in cardiovascular indications].
    Lorenz R
    Internist (Berl); 1989 May; 30(5):315-21. PubMed ID: 2661475
    [No Abstract]   [Full Text] [Related]  

  • 14. [Four years of circulatory support with the INCOR axial pump from Berlin Heart].
    Kirsch M; Vermes E; Boval B; Drouet L; Loisance D
    Arch Mal Coeur Vaiss; 2007 Nov; 100(11):967-70. PubMed ID: 18209700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of antithrombotic therapy according to CHA2DS2-VASc score in patients with atrial fibrillation in primary care.
    Barrios V; Escobar C; Calderón A; Rodríguez Roca GC; Llisterri JL; Polo García J
    Rev Esp Cardiol (Engl Ed); 2014 Feb; 67(2):150-1. PubMed ID: 24795129
    [No Abstract]   [Full Text] [Related]  

  • 16. Targeting phosphodiesterases in anti-platelet therapy.
    Rondina MT; Weyrich AS
    Handb Exp Pharmacol; 2012; (210):225-38. PubMed ID: 22918733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biochemical and pharmacologic properties of platelet aggregants and platelet antiaggregants of viper venoms in Tunisia].
    Marrakchi N; Barbouche R; Zinghali L; Krifi M; Bon C; el Ayeb M
    Arch Inst Pasteur Tunis; 1994; 71(3-4):487-91. PubMed ID: 8801850
    [No Abstract]   [Full Text] [Related]  

  • 18. [New anti-platelet strategies].
    de Gaetano G; Cerletti C
    Ital Heart J Suppl; 2001 Jan; 2(1):7-9. PubMed ID: 11216085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New antithrombotics in the prevention of venous thromboembolia and new anti-platelet drugs].
    Malý J; Pecka M; Malý R
    Vnitr Lek; 2011 Sep; 57(9):733-9. PubMed ID: 21957766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-aggregants in 1990].
    Verstraete M
    Rev Med Interne; 1990; 11(3):209-15. PubMed ID: 2096418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.